NHS Injectable Medicines Guide Project Outline

Similar documents
NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas

Information Resources for NHS Hospital On-call Pharmacists in the East of England

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy

Medicines Management Strategy

DERBY HOSPITALS NHS FOUNDATION TRUST PROJECT FINAL SUMMARY REPORT. Purchasing for Safety - Injectable Medicines

Non Medical Prescribing Policy

Directorate: Medical Due for Review: June Ope Owoso, Medicines Optimisation Pharmacist. Table of Contents

Medicines Optimisation Patient Safety And Medication Safety. Dr David Cousins Associate Director Medication Safety and Medical Devices

Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Injectable Medicines Policy. (Prescribing, Preparing and Administering Injectable Medicines Policy)

Introduction of EPMA in paediatric practice in UK:

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR and SUBCUTANEOUS

Announcing the launch of the NICE BNF and NICE BNFC apps in Scotland, Sir Andrew Dillon, NICE Chief Executive, said:

Smart Pumps and Drug Libraries The Way Forward

SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING

Principles of Shared Care Protocols

UKMi and Medicines Optimisation in England A Consultation

FIRST PATIENT SAFETY ALERT FROM NATIONAL PATIENT SAFETY AGENCY (NPSA) Preventing accidental overdose of intravenous potassium

Recommendations from National Patient Safety Agency alerts that remain relevant to the Never Events list 2018

All areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final

Clinical Check of Prescriptions in Ward Areas

INJECTABLE MEDICINES POLICY

Document Details. notification of entry onto webpage

NON-MEDICAL PRESCRIBING POLICY

Section Title. Prescribing competency framework Catherine Picton, Lead author

NHS North Somerset Clinical Commissioning Group

The Medicines Policy. Chapter 6: Standards of Practice. MISCELLANEOUS and DISCHARGE

Administration of Intrathecal Cytotoxic Chemotherapy in NHS Grampian

Appendix 2 to NMP policy Prescribing Governance Framework Standards for Supplementary and Independent Non-Medical Prescribers at SCH

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

TECHNICAL PHARMACY CURRICULUM GUIDE 2011/12

Home therapy programme

Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure

LESSON ASSIGNMENT. Professional References in Pharmacy.

FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

Central purchase of the British National Formularies by NHS Evidence

PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS

Shared Care Agreements for Medicines

NHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives

NICE guideline 5: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes

Foundation Pharmacy Framework

All Wales Continuous Subcutaneous Infusion Medication Administration Record AWMR10

Wrong route administration of an oral drug into a vein

Medicines Policy v1.0

PGDs are permitted for use only by registered health professionals (see enclosed link for full list

Unlicensed Medicines Policy

Moving the Green Medicines Bag from the Safety Agenda to QIPP

SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY

North School of Pharmacy and Medicines Optimisation Strategic Plan

NHS community pharmacy advanced services Briefing for GP practices

Medicines Management Policy

MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY

Medicines Reconciliation: Standard Operating Procedure

SAFE Standard of Care

In-Patient Medication Order Entry System - contribution of pharmacy informatics

Unlicensed Medicines Policy Document

CCG Policy for Working with the Pharmaceutical Industry

JOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.

Our pharmacist led care home service

Systemic Anti-Cancer Therapy Delivery. June 2017 National External Review

Derby Hospitals NHS Foundation Trust. Drug Assessment

Martina Khundakar - Senior Clinical Pharmacist Teresa Barnes - Lead Clinical Pharmacist - Specialist Care. Timothy Donaldson, Trust Chief Pharmacist

RPS in Scotland has had an influential year providing both written and oral evidence at the Scottish Parliament in a wide range of policy areas.

POLICY FOR ANTICIPATORY PRESCRIBING FOR PATIENTS WITH A TERMINAL ILLNESS Just in Case

Prescribing & Medicines: Reimbursement and remuneration paid to dispensing contractors

The Role of the Neurology Specialist Pharmacist In the management of Parkinson's Disease. Janine Barnes PhD

ANTIBIOTIC ADMINISTRATION & MEDICATION ERROR AND REPORTING 12 th APRIL 2010

Safe and Secure. Use of Medicines Policy and

Health & Social Services

Pharmacist (Palliative Care) December 2014 Page 1

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes

Provide Safe and Effective Medicines Management in Primary Care

SFHPHARM29 - SQA Unit Code FA3A 04 Take a medication history

The Prescribing, Monitoring and Administration of Depot / Long Acting IM Medication within Community Mental Health Services

Medication safety monitoring programme in public acute hospitals - An overview of findings

Dr Vincent Kirchner, MEDICAL DIRECTOR. Date Version Summary of amendments Oct New Procedure

Policy for the administration of subcutaneous medications via the McKinley Syringe Driver. July

NICE Charter Who we are and what we do

Community Pharmacy Future

SystmOne COMMUNITY OPERATIONAL GUIDELINES

NUH Medicines Policy: Code of Practice. NUH Intravenous Drug Administration Policy

Contents. About the Pharmacists Defence Association. representing your interests

Intravenous Infusion Practices and Patient Safety: Insights from ECLIPSE

JOB DESCRIPTION. Pharmacy Technician

Schedule C1. Community Pharmacy Anti-Coagulation Management Services

Improving the reporting of medication-related safety incidents

The roles and relationships of the organisations involved in NHS Chaplaincy in England

Guidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products

Pre-registration. e-portfolio

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

Procedure 26 Standard Operating Procedure for Controlled Drugs in homes within NHS Sutton CCG

ADMINISTRATION BY INJECTION POLICY INTRAVENOUS, INTRAMUSCULAR AND CENTRAL LINES

Guidance on Standard Operating Procedures for the Safer Management of Controlled Drugs in Registered Facilities. July 2011

DERBY HOSPITALS NHS FOUNDATION TRUST. Final Report. Purchasing for safety - Injectable medicines

Medication Management Policy and Procedures

Transcription:

NHS Injectable Medicines Guide Project Outline Peter Golightly Director - Trent Medicines Information Service

The Concept Provision of an authoritative and comprehensive single source of evidence-based information on injectable medicines for use throughout the NHS in the UK and in other appropriate healthcare settings to maximise patient safety

The Driver NPSA Patient Safety Alert 20 Promoting safer use of injectable medicines 3. Ensure essential technical information on injectable medicines is available and accessible to healthcare staff in clinical areas at the point of use. Some injectable medicines do not have a package insert providing essential technical information about preparation and administration, or the information is insufficient to fully meet the needs of all healthcare staff. For example, an incompatibility between the diluent, infusion, other medicines or administration devices, and associated administration equipment. This technical information is not available in commonly used medicines references such as the British National Formulary. A detailed guide to the safe preparation and administration of common intravenous medicines is available via NHSnet. The Injectable Guide is produced by pharmacists based in approximately 100 different UK hospitals and co-ordinated by the pharmacy department at Hammersmith Hospitals NHS Trust. A new partnership between The Injectable Guide and United Kingdom Medicines Information Service (UKMi) has been formed to expand and develop the content and availability.

What sources are there now? IV Guide BNF SPC/PIL UCL IV Guide Trissel King Guide Hospital IV Guides (>30)

Primary Content IV (mainstream and specialist) Epidurals / spinals Subcutaneous infusions Other high risk situations/routes Secondary Prioritised by risk Specialist admin routes Blood products (BNF) Specialist drugs (e.g. Botox) Lower risk IM and SC injectables Licensed, unlicensed, off-label

NPSA Data Content Reconstitution Concentration of final solution Example calculations Dilution/flush solutions Stability in solution Administration rate Compatibility information (for commonly used mixtures in specialist areas only) Special handling information Specialist technical information (where relevant)

IMG Additional Data Adverse effects on injection Infusion pump information Product risk factor/assessment Electronic links to external sources

The Core Partners IV Guide Group Subject knowledge/experience; proven product; NHS-wide penetration; collaborative writing, multidisciplinary links UKMi RPSGB DoH UK wide; Evidence-based publications; reputation for quality and governance-based products; multidisciplinary links Professional umbrella; links with other professional organisations NHS-wide endorsement; policy and strategic links

External Partners/Stakeholders Specialist clinical users/contributors e.g. oncology, anaesthetics Multidisciplinary users/contributors e.g. nurses, doctors, pharmacists Primary and secondary care NHS and non-nhs healthcare providers Pharmaceutical industry

Delivering the Product - Options Available at point-of of-care/application Electronic Medusa NeLM e-prescribing Commercial provider PC/laptop, PDA, phone Paper From e-version e or standalone Selective local printing Keeping up-to to-date Commercial publishing date (user and publisher issues)

Production & Control Options 1. Principles Trained, accredited, committed and reliable writers Comprehensive and guaranteed checking and governance framework Multidisciplinary and multispeciality input at all process stages User and stakeholder responsive Responsive to product changes Product is, at all times, up-to to-date and fit- for-purpose

Production & Control Options 2. Structure Project Board Overall management and strategic leadership, incl. funding Major stakeholders and national users groups Editorial Group Monograph consistency, policy adherence Editor, IT, admin Team Leads Co-ordinate ordinate local writers/checkers, implement local training, accreditation and QA Regional UKMi Clinical Steering Group Advising on clinical content, style, format, and delivery Editor/ professional group reps, patient safety reps Operational Network Gps Writing and checking Regional UKMi Team Leads, writers, checkers

Hurdles Writers and checkers Multidisciplinary and specialist input NHS-wide endorsement (DoH/NPSA) Project & maintenance funding Delivery platforms Creating move-forward and embrace change cultures Maintaining long-term momentum

Project Summary 1 Develop an NHS-Injectable Medicines Guide to support patient safety and minimise risks with injectable medicines Build on the current IV Guide and the interim work being undertaken to bring it up-to to-date Create a robust writing, training and clinical governance framework Develop appropriate electronic and/or paper delivery platforms

Project Summary 2 Create a management structure which involves all key users, stakeholders and clinical disciplines Develop and implement a production plan for all injectable medicines used in the NHS, prioritised according to risk (n=~700) Identify funding for a 2-32 3 year development project and then ongoing maintenance Roll-out out across the NHS and make available to non-nhs healthcare providers

Next Steps Stakeholder consultation on the product and the project Rewrite preliminary business plan DoH facilitate identification of funding Start project

and now for your help In developing the project, what are the user and stakeholder views on: 1. Format and content 2. Delivery platforms 3. Successful implementation 4. Multidisciplinary writing input